During the West Africa Ebola outbreak, International Medical Corps and Scripps Translational Science Institute (STSI) tested the feasibility of a wireless patient monitoring system in providing real-time, remote monitoring of patient signs inside an Ebola treatment facility.
The three-week trial took place in International Medical Corps’ Ebola Treatment Center (ETC) in Makeni, Sierra Leone and focused on the MultiSense patch. Placed on the patient’s chest, the MultiSense patch was developed by STSI and monitors patient vital signs and other information and sends it via Android phone from high-risk to low-risk areas, where it can be monitored by clinicians. The study, which took place over three weeks and included 26 patients, found that the MultiSense patch can provide highly accurate patient monitoring and can potentially be utilized in future outbreaks.
The full design and findings of this study can be found in an article published in the British Medical Journal on July 18, 2016.
More information can be found here:
Validation of a portable, deployable system for continuous vital sign monitoring using a multiparametric wearable sensor and personalized analytics in an Ebola treatment center